Criador Labs is an ISO13485-certified multidisciplinary medical device innovation and design studio in Bengaluru, India that brings revolutionary ideas to life, helping clients through the difficulties and challenges in innovation, delivering efficient, effective, and long-lasting success. From its inception, Criador Labs has utilized the best new-age technologies for its clients, completing over 100+ client projects, producing over 50+ prototypes, and 10+ product manufacturings. #productdesign #design #productdevelopment #medicaldevices #medicaldevicedevelopment #medicaldevicedesign #healthtech #medtech #medicaldevicemanufacturing #prototyping #electronics #mechanical

India is increasingly becoming a preferred destination for the global pharmaceutical supply chain, according to a recent report by Macquarie. The country’s strong manufacturing capabilities, cost efficiency, and regulatory reforms are driving its growth in the sector. The report highlights that India’s pharmaceutical industry, already valued at over $50 billion, is poised for further expansion as global companies seek to reduce dependence on China. With a well-established ecosystem of raw material suppliers, skilled workforce, and world-class production facilities, India offers a competitive edge in active pharmaceutical ingredients (APIs) and generic medicines. Government initiatives such as the Production-Linked Incentive (PLI) scheme and policy support for domestic API production have further strengthened India’s position. Additionally, rising investments in research and development (R&D) and the adoption of advanced technologies, including AI-driven drug discovery and digital healthcare solutions, are making India an attractive hub for global pharma giants. With increasing partnerships, export growth, and a favorable policy landscape, India is set to play a crucial role in ensuring a resilient and diversified global pharmaceutical supply chain. As multinational firms continue to shift their sourcing strategies, India stands out as a key beneficiary of this transformation. #PharmaceuticalIndustry #IndiaPharma #GlobalSupplyChain #APIs #DrugManufacturing #HealthcareInnovation #MedTech #PharmaGrowth #MakeInIndia #PLI #HealthcareStartups #DigitalHealth #Biopharma #R&D #AIinHealthcare #PharmaExports #SupplyChainResilience #HealthcareTech #Dseidehealthcarenetwork Source: Financial Express

Higher tariffs imposed by the U.S. on certain pharmaceutical imports from India are unlikely to impact the country’s competitive edge in the American market, according to industry experts. India remains a dominant player in the U.S. pharmaceutical sector, supplying around 40% of generic drugs. Factors such as cost-efficient manufacturing, a skilled workforce, and regulatory compliance continue to support India’s strong market presence. While the Biden administration has increased tariffs on some Chinese pharmaceutical ingredients, India is seen as a reliable alternative for drug production. The Indian pharmaceutical industry has also been expanding its manufacturing capabilities, reducing dependence on Chinese raw materials. This shift enhances supply chain resilience and ensures steady exports to the U.S. Industry leaders believe that India’s ability to produce affordable, high-quality medicines will help it withstand tariff changes. Additionally, ongoing investments in research and development (R&D), innovation, and adherence to U.S. FDA standards reinforce India’s position as a preferred supplier. Despite potential short-term cost pressures, Indian pharmaceutical firms are expected to remain competitive by leveraging economies of scale and focusing on high-value drug formulations. The long-term outlook remains positive, driven by global demand for affordable medicines and strong bilateral trade relations. #IndiaPharma #USPharmaMarket #GenericDrugs #PharmaExports #TradeRelations #HealthcareIndustry #MedTech #Tariffs #PharmaManufacturing #SupplyChain #AffordableMedicine #PharmaInnovation #DrugSupply #FDACertified #HealthTech #GlobalPharma #PharmaceuticalIndustry #dseidehealthcarenetwork Source: Financial Express

Manipal Government of Karnataka Bioincubator-BioNEST is conducting a Technical Talk on "Pharmaceutical Manufacturing , Operations, cGMP Systems & Regulatory Challenges" . This program will be very helpful to Students, Innovators, Researchers, Entrepreneurs, and anyone who would like to get an insight in product manufacturing, cGMP systems, regulatory requirements and challenges, especially into the details of sterile product manufacturing process. Date: 30-01-2025, Thursday Time: 11.30 AM - 12:30 PM Speaker: Dr. Girish Pai K, Associate Professor | Department of Pharmaceutics | Co-ordinator, Centre for cGMP| Manipal College of Pharmaceutical Sciences |Manipal Academy of Higher Education| Manipal - 576 104 Dr. Pai has gained tremendous industry experience before coming to academia. He has worked for AstraZeneca Pharma (India), Orchid Healthcare (India), Neopharma LLC (Abu Dhabi, UAE) and CFL Pharmaceuticals Ltd (India) before joining MCOPS, MAHE. The session will cover: Brief introduction Pharmaceutical manufacturing operations (flow chart with an example) cGMP systems to be adopted Role of Quality Assurance Pharmaceutical quality issues Real life cases and its investigations Regulatory challenges Conclusions. Q & A session. Platform: Microsoft Teams; online Registration Link: https://tinyurl.com/yc7u7ndy Registration will be opened till 29-01-2025, 04:00 PM Registration Fee: INR 99/- Microsoft teams link for online talk will be shared on 29-01-2025 at 05:00 PM for registered participants The recording of the session will be shared with all the registered participants. Certificates will be provided to the registered participants (both, attending online as well as offline)

Registration Link: https://tinyurl.com/yc7u7ndy Manipal Government of Karnataka Bioincubator-BioNEST is conducting a Technical Talk on "Pharmaceutical Manufacturing , Operations, cGMP Systems & Regulatory Challenges" . This program will be very helpful to Students, Innovators, Researchers, Entrepreneurs, and anyone who would like to get an insight in product manufacturing, cGMP systems, regulatory requirements and challenges, especially into the details of sterile product manufacturing process. Date: 30-01-2025, Thursday Time: 11.30 AM - 12:30 PM Speaker: Dr. Girish Pai K, Associate Professor | Department of Pharmaceutics |Co-ordinator, Centre for cGMP| Manipal College of Pharmaceutical Sciences |Manipal Academy of Higher Education| Manipal - 576 104 The session will cover: 1. Brief introduction 2. Pharmaceutical manufacturing operations (flow chart with an example) 3. cGMP systems to be adopted 4. Role of Quality Assurance 5. Pharmaceutical quality issues 6. Real life cases and its investigations 7. Regulatory challenges 8. Conclusions. 9. Q & A session. Platform: Microsoft Teams; online Registration Link: https://tinyurl.com/yc7u7ndy Registration will be opened till 29-01-2025, 04:00 PM Registration Fee: INR 99/- till 24-01-2025 INR 299/- post 24-01-2025 Microsoft teams link for online talk will be shared on 29-01-2025 at 05:00 PM for registered participants Certificates will be provided.

Dseide Healthcare Network was proud to serve as a Community Partner for the PharmaTech and LabTech Expo 2025 🎉, held from January 8-10, 2025, at the Bengaluru International Exhibition Centre 🏢. Event Overview The expo showcased over 200 exhibitors 🛠️ and attracted approximately 6,000 visitors 👥, making it a key platform for advancements in the pharmaceutical and biotech industries. It featured innovative lab equipment, packaging solutions, and active pharmaceutical ingredients 💊. Dseide's Role As a Community Partner, Dseide facilitated connections among participants 🤝, promoting collaboration and knowledge sharing within the healthcare ecosystem 🌐. The event included educational conferences 📚 and networking opportunities that enhanced engagement among industry professionals. #PharmaTechExpo2025 #LabTechExpo2025 #Dseide #HealthcareInnovation #Pharmaceuticals #HealthTech #PharmaIndustry #Biotech #PharmaManufacturing #Networking #InnovationInHealthcare #BengaluruExpo #TradeShow2025

Best Manufacturer Award The Best Manufacturer Award at HOSPEX Healthcare Expo 2024 recognizes excellence in medical equipment manufacturing, honoring companies that have demonstrated exceptional quality, innovation, and reliability in their products. This prestigious award highlights manufacturers who have set industry benchmarks, delivering cutting-edge medical equipment that enhances patient care and supports healthcare professionals in their work. By celebrating those who prioritize precision, durability, and technological advancement, the Best Manufacturer Award underscores the importance of high standards in medical equipment production. Winners are chosen by a panel of industry experts, acknowledging their commitment to excellence and their role in advancing healthcare technology.